ArticleACS medicinal chemistry letters2025

Discovery of HMPL-306 (Ranosidenib), a New Potent and Selective Dual Inhibitor of Mutant IDH1 and 2 in Clinical Development for Cancer Treatment.

Kun Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.